Damon Runyon Cancer Research Foundation

Thrilled to join the 2025 cohort of Damon Runyon fellows!

Honored to be named an HHMI Fellow of the Damon Runyon Cancer Research Foundation among these amazing scientists! Very grateful for the support for my postdoctoral research in the Rudensky lab.

In 5 weeks we will be trekking Everest, but in 2 weeks we will be getting together to discuss how we can make advanced therapies accessible to all of those in need. Please join us on March 18, 2025, at the Broad Institute of MIT and Harvard in Cambridge, MA for: Crossing The Chasm: Navigating Innovation and Access to Advanced Therapies! We’re bringing together leaders in science, policy, and industry to explore the cutting-edge of cell and gene therapy, discuss real-world challenges, and chart a path for delivering life-changing treatments at scale. With keynotes from Dr. Kristen Hege and Dr. Guangping Gao, plus insight-packed panels on policy, community-level therapy delivery, and more, this event will spark collaboration and fresh perspectives. Best of all, 100% of proceeds from tickets and sponsorships go directly to support the Damon Runyon Cancer Research Foundation and its mission to fund high-risk, high-reward cancer research. Our goal is to raise $700,000—and with your help, we can achieve it. If you’re passionate about the future of healthcare, the promise of advanced therapies, and empowering the next generation of cancer researchers, you won’t want to miss it. Secure your spot and partner with us to forge the future of advanced therapies: Get your tickets at the link in the comments section and reach out to me, Adam Clark, or Martin Strebl-Bantillo, PhD for sponsorship information. We could really use your support to hit our ambitious goal! #AdvancedTherapies #CancerResearch #HealthcareInnovation #Biotech #Networking #Philanthropy

I am deeply honored to be selected as a DAMON RUNYON fellow. I'll do my best to answer brave and bold scientific questions. I always grateful to Roger and team for their great support!

We are delighted to announce our most recent class of Damon Runyon Fellows! These 13 scientists will receive four years of independent funding to investigate cancer causes, mechanisms, therapies, and prevention. In addition, the Foundation has also named five recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists. This award recognizes Damon Runyon Fellows who have exceeded the Foundation’s highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose, and treat cancer. “The Fellowship’s emphasis on innovation has inspired me to pursue bold, high-risk ideas that I might have otherwise hesitated to explore,” said 2025 Dale Frey Awardee Fangyu Liu, PhD. Read more: https://bit.ly/4kv5JLF

Join us in NYC for Cancer Progress on April 2, 2025 for a day dedicated to transformative insights from leading experts in the field. Dive into groundbreaking advancements and network with innovators who are driving change in oncology. Thank you to our amazing sponsors Bristol Myers Squibb, IO Biotech, Arsenal Capital Partners, BioInvent International AB and Nurix Therapeutics for your unwavering commitment to the fight against cancer! We are incredibly grateful for your generous support makes this event possible. 100% of proceeds from ticket sales and sponsorships will directly benefit the Damon Runyon Cancer Research Foundation as part of the Luke Timmerman 2025 Traverse. Register Now: https://buff.ly/4igk1hc #CancerProgress #Oncology #CancerResearch #TimmermanTraverse #DamonRunyonCancerResearchFoundation #NYCEvents #ShapeTheFuture #InnovationInOncology

13 years ago, I faced a life-altering moment when diagnosed with bilateral pulmonary emboli, an event that reshaped my life. Despite being told I would never reach high altitudes again, this April marks a significant defiance of those odds. I am embarking on a trek to Everest Base Camp at 18,000 feet alongside 17 biotech executives. Our collective goal is to raise $700,000 for the Damon Runyon Cancer Research Foundation, a crucial initiative funding groundbreaking research that directly impacts / saves lives. This endeavor holds immense personal significance as I have dedicated 25 years to combating cancer, witnessing its profound effects firsthand. Beyond the physical challenge of scaling a mountain, this journey embodies themes of hope, progress, and honoring the memories of those we have lost along the way. Your support in this endeavor is not just about climbing a peak but about contributing to a cause that transcends boundaries and brings light to the fight against cancer. ?? of proceeds go to Damon Runyon Cancer Research Foundation Donate here: https://lnkd.in/gi9G7Fsc

In the wake of recent NIH cuts, organizations like Damon Runyon Cancer Research Foundation are essential in supporting our basic science & clinical research. I am incredibly grateful that my postdoctoral research can continue thanks to this fellowship. Join me in fundraising for the next year’s fellows: https://lnkd.in/eRsaXiZN

New research from Damon Runyon alumnus and current Committee Member Howard Y. Chang, MD, PhD, and colleagues, including Damon Runyon Fellow Xiaowei Yan, PhD, reveals how some cancers are driven by extrachromosomal DNA—circular pieces of DNA that seem to defy Mendelian genetics. Read more: https://bit.ly/3QiKhM1

Looking for ways to show love today ??? Buy tickets to the ultimate Cancer Research fundraising event on March 18th "Crossing the Chasm." In less than 8 weeks, I will be joined by 17 biotech executives who are "Crossing the Chasm" both professionally and personally to raise more than $700,000 by trekking to Everest Base Camp and donating 100% of proceeds to Damon Runyon Cancer Research Foundation.